Skip to main content
Clinical Trials/NCT07035080
NCT07035080Not yet recruitingNot Applicable

Efficacy Of Isokinetic Strength Training On Functional Performance In Children With Hemophilia

Kafrelsheikh University0 sites30 target enrollmentStarted: June 20, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
30
Primary Endpoint
changes in muscle strength

Study Overview

Brief Summary

Hemophilia is a congenital , recessive clotting disease featured by cerebra ( The most dangerous ) and musculoskeletal (the most common and disabling) hemorrhages . It is a gender -specific coagulopathy resulting from a factor VIII (F VIII) deficiency in hemophilia A and factor IX (F IX) deficiency in hemophilia B( Felip et al., 2011) Loss of muscle mass is typical of hemophilia arthropathy, There are two basic reasons that account for such muscle loss. The first reason is due to inactive joints as the result of long -term immobilization that hemophilic patients are obliged to do because of continuous lesions in muscles and joints, and the second reason is a decrease in physical exercise by hemophilic patients because of the risk of lesions that they face (Toca-Herrera et al., 2008).

Interferential therapy is a type of transcutaneous electrical nerve stimulation (TENS). Two slightly different, medium frequency- alternating currents are simultaneously applied to the affected area through electrodes. Superpisition or interference between the currents causes the combined electrical current to rise and fall (Burch et al, 2008).

Low amplitude modulated frequencies elicit a "beating" or "tapping" sensation and muscle twitch response, while higher amplitude modulated frequencies elicit "buzzing" or "tingling sensation" and titanic muscle contraction ( Defrin et al., 2007).

Several methods are available for testing muscle strength. These include manual muscle testing and dynamometry includes the use of handheld dynamometers, handgrip dynamometers, and isokinetic dynamometers (Sisto and Dyson-hudson, 2007).

Isokinetic dynamometers measure torque produced at the anatomic joint throughout the available range of motion (ROM). Isokinetic dynamometers. Such as the kinCom (Chatanooga Corp, Chatanooga, Tennessee). Biodex (Biodex Medical systems. Inc) and Lido Active isokinetic System (Loredan, Inc, Davis , California ) measure torque by controlling the velocity of the movement and measuring the force applied via a force transducer (Sisto and Dyson-hunson, 2007).

Isokinetic test record the torque produced throughout the entire ROM and allow for the identification of regions of strength or weakness within the range ( Remauld et al., 2005).

Isokinetic assessment has primarily been recommended for strength testing as maximal force is applied during all phase of the movement at a constant velocity . The isokinetic mode is also safe to use with children because there is minimal risk of the muscle and joint injuries that can results from efforts to control the load if using free weights in one repetition -maximum testing (Mark et al., 2003).

Detailed Description

Loss of muscle mass is typical of hemophilia arthropathy, There are two basic reasons that account for such muscle loss. The first reason is due to inactive joints as the result of long -term immobilization that hemophilic patients are obliged to do because of continuous lesions in muscles and joints, and the second reason is a decrease in physical exercise by hemophilic patients because of the risk of lesions that they face (Toca-Herrera et al., 2008).

With time , hemophilic arthropahy results in weak and unstable joints. The patient is also very vulnerable to stressful locomotors stimulation, which, in turn, causes greater instability and risk of lesions. This cicious circle of pain immobility , atrophy , joint instability , and new hemorrhagic episodes may eventually lead to total invalidity ( Gomis et al., 2009).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
8 Years to 12 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients of both groups (study and control groups ) were selected according to the following criteria:
  • •Each group contained 15 male children. They were suffering from unilateral knee heamarthrothesis .
  • •The joint problems (pain and bleeding ) ranges from mild to moderate according to the classification of hemophilia recommended by the Orthopedic advisory committee of the World Federation of hemophilia (appendix 1) (Holder and Cotta, 1989).
  • •Patients were able to stand and walk independently.
  • •They had no neurological or psychological problems.
  • •All patients were clinically and medically stable.
  • •They were able to understand the requirements of the study.
  • •They were suffering from moderate hemophilia.
  • •They were not suffering from acute joint and muscle bleeds during treatment time.
  • •None of the children suffered from fixed deformities of the affected lower limb.
  • •All the children received the same medical treatment to control bleeding.
  • •They had no visual no hearing deficits B.

Exclusion Criteria

  • •Patients with advanced radiographic changes including:
  • •Bone destruction.
  • •Bony ankylosis .
  • •Knee joint subluxation.
  • •Epiphyseal fracture.
  • •Patients who had congenital or acquired skeletal deformities in both lower limbs.
  • •Patients who had any neurological deficits such as convulsions involuntary movements or those receiving muscle relaxants.
  • •Exclusion Criteria:

Arms & Interventions

group 1

Experimental

the control group will receive traditional treatment program for one hour per session including (ultrasound stretching and strengthening exercise )

Intervention: tradional physical therapy (Other)

group 2

Experimental

the study group will receive interferential therapy in addition to the same treatment program given to the control groups.

Intervention: interferential therapy (Other)

Outcomes

Primary Outcomes

changes in muscle strength

Time Frame: after 3 months

Secondary Outcomes

  • change in level of pain(after 3 months)
  • change in function ability(after 3 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sara Yousef Abdel Elglil Yousef Elsebahy

lecture of pediatric physical therapy

Kafrelsheikh University

Similar Trials